Clinical Trial Update: Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC) [Phase 1]

View source ↗

Summary

Phase 1b double-blind, placebo-controlled study of RO7049665 in ulcerative colitis terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• RO7049665

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ulcerative Colitis | Phase 1 | Status: TERMINATED | Results posted: 2024-02-15